Literature DB >> 1552216

Failure to ameliorate Creutzfeldt-Jakob disease with amphotericin B therapy.

C Masullo, G Macchi, Y G Xi, M Pocchiari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1552216     DOI： 10.1093/infdis/165.4.784

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  14 in total

Review 1.  Rapidly progressive dementias and the treatment of human prion diseases.

Authors:  Brian S Appleby; Constantine G Lyketsos
Journal:  Expert Opin Pharmacother       Date:  2010-11-23       Impact factor: 3.889

Review 2.  Prions: Beyond a Single Protein.

Authors:  Alvin S Das; Wen-Quan Zou
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

3.  Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals.

Authors:  R Demaimay; K T Adjou; V Beringue; S Demart; C I Lasmézas; J P Deslys; M Seman; D Dormont
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Elimination of prions by branched polyamines and implications for therapeutics.

Authors:  S Supattapone; H O Nguyen; F E Cohen; S B Prusiner; M R Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

Review 5.  Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: implications for physicians.

Authors:  C MacKnight; K Rockwood
Journal:  CMAJ       Date:  1996-09-01       Impact factor: 8.262

Review 6.  Therapies for human prion diseases.

Authors:  Peter K Panegyres; Elizabeth Armari
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

7.  Calcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survival.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Dennisse Gonzalez-Romero; Kristi Green; Giulio Taglialatela; Claudio Soto
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

8.  Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures.

Authors:  Sabrina Cronier; Vincent Beringue; Anne Bellon; Jean-Michel Peyrin; Hubert Laude
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

Review 9.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

10.  Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness in Prion-Infected Mice.

Authors:  Daisuke Ishibashi; Takeshi Ishikawa; Satoshi Mizuta; Hiroya Tange; Takehiro Nakagaki; Tsuyoshi Hamada; Noriyuki Nishida
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.